Measuring myocardial salvage

Cardiovascular Research

Volumn 94, Issue 2, 2012, Pages 266-275

  Bøtker, Hans Erik ^a   Kaltoft, Anne Kjer ^a   Pedersen, Steen Fjord ^a   Kim, Won Yong ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acute myocardial infarction; Area at risk; Cardioprotection; Cardiovascular magnetic resonance; Myocardial salvage

Indexed keywords

GADOLINIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTRAST ENHANCEMENT; DRUG DISTRIBUTION; DRUG HALF LIFE; ECHOCARDIOGRAPHY; HEART INFARCTION SIZE; HEART MUSCLE REVASCULARIZATION; HEART MUSCLE SALVAGE; HEART PROTECTION; HEART VENTRICULOGRAPHY; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION EXPOSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIUM; RISK ASSESSMENT; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84860184540     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs081     Document Type: Review

References (73)

1. Van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998;97:2302-2306. (Pubitemid 28280383)
2. Svilaas T, Vlaar PJ, van der Horst IC, Diercks GFH, de Smet BJGL, van den Heuvel AFM et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008;358:557-567. (Pubitemid 351214283)
3. Kaltoft A, Bottcher M, Sand NP, Rehling M, Andersen NT, Zijlstra F et al. Sestamibi single photon emission computed tomography immediately after primary percutaneous coronary intervention identifies patients at risk for large infarcts. Am Heart J 2006;151:1115-1121.
4. Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial. Lancet 2002;359: 920-925. (Pubitemid 34246380)
5. Schomig A, Mehilli J, Antoniucci D, Ndrepepa G, Markwardt C, Di Pede F et al. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 h from symptom onset: a randomized controlled trial. JAMA 2005;293:2865-2872. (Pubitemid 41029140)
6. Kaltoft A, Bottcher M, Nielsen SS, Hansen HH, Terkelsen C, Maeng M et al. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial. Circulation 2006;114:40-47. (Pubitemid 44305273)
7. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010;375:727-734.
8. van Hellemond IE, Bouwmeester S, Olson CW, Botker HE, Kaltoft AK, Nielsen SS et al. Consideration of QRS complex in addition to ST-segment abnormalities in the estimated 'risk region' during acute anterior myocardial infarction. J Electrocardiol 2011;44:370-376.
9. Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 2011;301:H1723-H1741.
10. O'Connor MK, Hammell T, Gibbons RJ. In vitro validation of a simple tomographic technique for estimation of percentage myocardium at risk using methoxyisobutyl isonitrile technetium 99m (sestamibi). Eur J Nucl Med 1990;17:69-76. (Pubitemid 20342947)
11. Busk M, Kaltoft A, Nielsen SS, Bottcher M, Rehling M, Thuesen L et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for,12 vs. 12-72 h. Eur Heart J 2009;30:1322-1330.
12. Ndrepepa G, Mehilli J, Schwaiger M, Schuhlen H, Nekolla S, Martinoff S et al. Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. J Nucl Med 2004;45:725-729. (Pubitemid 47618548)
13. Eitel I, Desch S, Fuernau G, Hildebrand L, Gutberlet M, Schuler G et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010;55: 2470-2479.
14. Larose E, Rodes-Cabau J, Pibarot P, Rinfret S, Proulx G, Nguyen CM et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol 2010;55:2459-2469.
15. Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988;12:1573-1581.
16. Glover DK, Okada RD. Myocardial technetium 99m sestamibi kinetics after reperfusion in a canine model. Am Heart J 1993;125:657-666. (Pubitemid 23079829)
17. Canby RC, Silber S, Pohost GM. Relations of the myocardial imaging agents 99mTc-MIBI and 201T1 to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation 1990;81:289-296. (Pubitemid 20031793)
18. Okada RD, Williams SJ, Glover DK, Dragatokis D. Cardiac imaging and myocardial kinetics of technetium-tertiary butyl-isonitrile during dipyridamole-induced hyperemia. Am Heart J 1988;116:979-988.
19. Beanlands RS, Dawood F, Wen WH, McLaughlin PR, Butany J, D'Amati G et al. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability? Circulation 1990;82:1802-1814. (Pubitemid 20367983)
20. Kaltoft A, Nielsen SS, Terkelsen CJ, Bottcher M, Lassen JF, Krusell LR et al. Scintigraphic evaluation of routine filterwire distal protection in percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: a randomized controlled trial. J Nucl Cardiol 2009;16:784-791.
21. Kloner RA, Braunwald E. Observations on experimental myocardial ischaemia. Cardiovasc Res 1980;14:371-395.
22. Poulsen RH, Botker HE, Rehling M. Postreperfusion myocardial technetium-99m-sestamibi defect corresponds to area at risk Experimental results from an ischemia-reperfusion porcine model. Nucl Med Biol 2011;38:819-825.
23. Ndrepepa G, Mehilli J, Martinoff S, Schwaiger M, Schomig A, Kastrati A. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. J Am Coll Cardiol 2007;50:149-156. (Pubitemid 47002186)
24. Medrano R, Lowry RW, Young JB,Weilbaecher DG, Michael LH, Afridi I et al. Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study. Circulation 1996;94:1010-1017. (Pubitemid 26292854)
25. Kristensen J, Mortensen UM, Nielsen SS, Maeng M, Kaltoft A, Nielsen TT et al. Myocardial perfusion imaging with Tc-99m sestamibi early after reperfusion reliably reflects infarct size reduction by ischaemic preconditioning in an experimental porcine model. Nucl Med Com 2004;25:495-500. (Pubitemid 38591111)
26. Miller TD, Hodge DO, Sutton JM, Grines CL, O'Keefe JH, DeWood MA et al. Usefulness of technetium-99m sestamibi infarct size in predicting posthospital mortality following acute myocardial infarction. Am J Cardiol 1998;81:1491-1493. (Pubitemid 28283833)
27. Baer FM, Smolarz K, Theissen P, Voth E, Schicha H, Sechtem U. Regional 99mTc-methoxyisobutyl-isonitrile-uptake at rest in patients with myocardial infarcts: comparison with morphological and functional parameters obtained from gradient-echo magnetic resonance imaging. Eur Heart J 1994;15:97-107.
28. Gibbons RJ. Tc-99m SPECT sestamibi for the measurement of infarct size. J Cardiovasc Pharmacol Ther 2011;16:321-331.
29. Schomig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 2000;343:385-391. (Pubitemid 30626120)
30. Kastrati A, Mehilli J, Nekolla S, Bollwein H, Martinoff S, Pache J et al. A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J Am Coll Cardiol 2004;43:734-741. (Pubitemid 38296468)
31. Schomig A, Ndrepepa G, Mehilli J, Dirschinger J, Nekolla SG, Schmitt C et al. A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol 2004;44:2073-2079. (Pubitemid 39473294)
32. Kastrati A, Mehilli J, Schlotterbeck K, Dotzer F, Dirschinger J, Schmitt C et al. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. JAMA 2004;291:947-954. (Pubitemid 38543752)
33. Pache J, Kastrati A, Mehilli J, Bollwein H, Ndrepepa G, Schuhlen H et al. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J 2004;148:e3.
34. Munk K, Andersen NH, Schmidt MR, Nielsen SS, Terkelsen CJ, Sloth E et al. Remote ischemic conditioning in patients with myocardial infarction treated with primary angioplasty: impact on left ventricular function assessed by comprehensive echocardiography and gated single-photon emission CT. Circ Cardiovasc Imaging 2010;3: 656-662.
35. Sciagra R, Dona M, Coppola A, Leoncini M, Maioli M, Castagnoli A et al. Feasibility of an accurate assessment of myocardial salvage by comparing functional and perfusion abnormalities in post-reperfusion gated SPECT. J Nucl Cardiol 2010;17:825-830.
36. Sotgia B, Sciagra R, Parodi G, Kastrati A, Antoniucci D, Schomig A et al. Estimate of myocardial salvage in late presentation acute myocardial infarction by comparing functional and perfusion abnormalities in predischarge gated SPECT. Eur J Nucl Med Mol Imaging 2008;35:906-911.
37. Miller TD, Gibbons RJ. Measuring myocardium at risk in acute myocardial infarction-a continuing challenge. J Nucl Cardiol 2010;17:778-780.
38. Germano G, Kavanagh PB, Berman DS. An automatic approach to the analysis, quantitation and review of perfusion and function from myocardial perfusion SPECT images. Int J Card Imaging 1997;13:337-346.
39. Van Train KF, Areeda J, Garcia EV, Cooke CD, Maddahi J, Kiat H et al. Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993;34:1494-1502. (Pubitemid 23254345)
40. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138-2147.
41. Germano G, Kavanagh PB, Waechter P, Areeda J, Van Kriekinge S, Sharir T et al. A new algorithm for the quantitation of myocardial perfusion SPECT. I: technical principles and reproducibility. J Nucl Med 2000;41:712-719. (Pubitemid 30207750)
42. Neizel M, Lossnitzer D, Korosoglou G, Schaufele T, Peykarjou H, Steen H et al. Strain-encoded MRI for evaluation of left ventricular function and transmurality in acute myocardial infarction. Circ Cardiovasc Imaging 2009;2:116-122.
43. Thiele H, Schindler K, Friedenberger J, Eitel I, Furnau G, Grebe E et al. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial. Circulation 2008;118:49-57.
44. Milavetz JJ, Giebel DW, Christian TF, Schwartz RS, Holmes DRJ, Gibbons RJ. Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol 1998;31:1246-1251. (Pubitemid 28219113)
45. Higgins CB, Herfkens R, Lipton MJ, Sievers R, Sheldon P, Kaufman L et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol 1983;52:184-188. (Pubitemid 13061350)
46. Friedrich MG, Kim HW, Kim RJ. T2-weighted imaging to assess post-infarct myocardium at risk. JACC Cardiovasc Imaging 2011;4:1014-1021.
47. Lonborg J, Vejlstrup N, Mathiasen AB, Thomsen C, Engstrom T. Myocardial area at risk and salvage measured by T2-weigthed cardiac magnetic resonance images-reproducibility and comparison of two T2-weigthed protocols. J Cardiovasc Magn Reson 2011;13:50.
48. Aletras AH, Kellman P, Derbyshire JA, Arai AE. ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. Magn Reson Med 2008;59:229-235. (Pubitemid 351220085)
49. O'Regan DP, Ahmed R, Karunanithy N, Neuwirth C, Tan Y, Durighel G et al. Reperfusion hemorrhage following acute myocardial infarction: assessment with T2* mapping and effect on measuring the area at risk. Radiology 2009;250:916-922.
50. Sorensson P, Heiberg E, Saleh N, Bouvier F, Caidahl K, Tornvall P et al. Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography. J Cardiovasc Magn Reson 2010;12:25.
51. Matsumoto H, Matsuda T, Miyamoto K, Shimada T, Mikuri M, Hiraoka Y. Peri-infarct zone on early contrast-enhanced CMR imaging in patients with acute myocardial infarction. JACC Cardiovasc Imaging 2011;4:610-618.
52. Reimer KA, Jennings RB. The 'wavefront phenomenon' of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979;40:633-644. (Pubitemid 9191795)
53. O'Regan DP, Ahmed R, Neuwirth C, Tan Y, Durighel G, Hajnal JV et al. Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary intervention. Am J Physiol Heart Circ Physiol 2009;297:H340-H346.
54. Ubachs JF, Engblom H, Erlinge D, Jovinge S, Hedstrom E, Carlsson M et al. Cardiovascular magnetic resonance of the myocardium at risk in acute reperfused myocardial infarction: comparison of T2-weighted imaging versus the circumferential endocardial extent of late gadolinium enhancement with transmural projection. J Cardiovasc Magn Reson 2010;12:18.
55. Fuernau G, Eitel I, Franke V, Hildebrandt L, Meissner J, de Waha S et al. Myocardium at risk in ST-segment elevation myocardial infarction comparison of T(2)-weighted edema imaging with the MR-assessed endocardial surface area and validation against angiographic scoring. JACC Cardiovasc Imaging 2011;4:967-976.
56. Arai AE. Magnetic resonance imaging for area at risk, myocardial infarction, and myocardial salvage. J Cardiovasc Pharmacol Ther 2011;16:313-320.
57. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-379. (Pubitemid 36164969)
58. Ibrahim T, Hackl T, Nekolla SG, Breuer M, Feldmair M, Schomig A et al. Acute myocardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion. Radiology 2010;254:88-97.
59. Lonborg J, Kelbaek H, Vejlstrup N, Jorgensen E, Helqvist S, Saunamaki K et al. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv 2010;3:34-41.
60. Freixa X, Bellera N, Ortiz-Perez JT, Jimenez M, Pare C, Bosch X et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 2012;33:103-112.
61. Lonborg J, Vejlstrup N, Kelbaek H, Botker HE, Kim WY, Mathiasen AB et al. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J. Epub ahead of print 14 September 2011; doi:10.1093/eurheartj/ehr309.
62. Verhaert D, Thavendiranathan P, Giri S, Mihai G, Rajagopalan S, Simonetti OP et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging 2011;4:269-278.
63. Carlsson M, Ubachs JF, Hedstrom E, Heiberg E, Jovinge S, Arheden H. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging 2009;2:569-576.
64. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008;359: 473-481.
65. Maruoka Y, Tomoike H, Kawachi Y, Noguchi K, Nakamura M. Relations between collateral flow and tissue salvage in the risk area after acute coronary occlusion in dogs: a topographical analysis. Br J Exp Pathol 1986;67:33-42. (Pubitemid 16050593)
66. Dash H, Johnson RA, Dinsmore RE, Harthorne JW. Cardiomyopathic syndrome due to coronary artery disease. I: relation to angiographic extent of coronary disease and to remote myocardial infarction. Br Heart J 1977;39: 733-739. (Pubitemid 8143684)
67. Wright J, Adriaenssens T, Dymarkowski S, Desmet W, Bogaert J. Quantification of myocardial area at risk with T2-weighted CMR: comparison with contrastenhanced CMR and coronary angiography. JACC Cardiovasc Imaging 2009;2: 825-831.
68. Ortiz-Perez JT, Meyers SN, Lee DC, Kansal P, Klocke FJ, Holly TA et al. Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging. Eur Heart J 2007;28:1750-1758. (Pubitemid 47227100)
69. Graham MM, Faris PD, Ghali WA, Galbraith PD, Norris CM, Badry JT et al. Validation of three myocardial jeopardy scores in a population-based cardiac catheterization cohort. Am Heart J 2001;142:254-261. (Pubitemid 32706283)
70. Berry C, Kellman P, Mancini C, Chen MY, Bandettini WP, Lowrey T et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging 2010;3:527-535.
71. Ortiz-Perez JT, Lee DC, Meyers SN, Davidson CJ, Bonow RO, Wu E. Determinants of myocardial salvage during acute myocardial infarction: evaluation with a combined angiographic and CMR myocardial salvage index. JACC Cardiovasc Imaging 2010;3:491-500.
72. Sorensson P, Saleh N, Bouvier F, Bohm F, Settergren M, Caidahl K et al. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 2010;96:1710-1715.
73. Mewton N, Rapacchi S, Augeul L, Ferrera R, Loufouat J, Boussel L et al. Determination of the myocardial area at risk with pre-versus post-reperfusion imaging techniques in the pig model. Basic Res Cardiol 2011;106:1247-1257.